MEDP Insider Trading

Insider Ownership Percentage: 20.30%
Insider Buying (Last 12 Months): $652.22
Insider Selling (Last 12 Months): $11,816,851.63

Medpace Insider Trading History Chart

This chart shows the insider buying and selling history at Medpace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$652bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$50M$0$50MTotal Insider BuyingTotal Insider Selling

Medpace Share Price & Price History

Current Price: $312.36
Price Change: Price Decrease of -4.25 (-1.34%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for MEDP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$312.36Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for Medpace (NASDAQ:MEDP)

77.98% of Medpace stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MEDP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.05Bbought$684MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1B-$500M$0$500M$1BTotal InflowsTotal Outflows
Medpace logo
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Read More on Medpace

Today's Range

Now: $312.36
Low: $311.54
High: $317.29

50 Day Range

MA: $335.90
Low: $312.36
High: $360.97

52 Week Range

Now: $312.36
Low: $302.01
High: $459.77

Volume

343,137 shs

Average Volume

298,736 shs

Market Capitalization

$9.52 billion

P/E Ratio

24.73

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of Medpace?

Medpace's top insider investors include:
  1. August J Troendle (CEO)
  2. Medpace Investors, Llc (Major Shareholder)
  3. Susan E Burwig (VP)
  4. Stephen P Ewald (General Counsel)
  5. Kevin M Brady (CFO)
  6. Ashley M Keating (Director)
  7. Robert O Kraft (Director)
Learn More about top insider investors at Medpace.

Who are the major institutional investors of Medpace?

Medpace's top institutional investors include:
  1. Vanguard Group Inc. — 8.27%
  2. Invesco Ltd. — 3.49%
  3. Wasatch Advisors LP — 3.01%
  4. Geode Capital Management LLC — 2.11%
  5. Bessemer Group Inc. — 1.85%
  6. Renaissance Technologies LLC — 1.78%
Learn More about top institutional investors of Medpace stock.

Which major investors are selling Medpace stock?

During the previous quarter, MEDP stock was sold by these institutional investors:
  1. Wellington Management Group LLP
  2. Wellington Management Group LLP
  3. Allspring Global Investments Holdings LLC
  4. Fuller & Thaler Asset Management Inc.
  5. Arrowstreet Capital Limited Partnership
  6. Iron Triangle Partners LP
  7. Los Angeles Capital Management LLC
  8. Schroder Investment Management Group

Which major investors are buying Medpace stock?

Within the previous quarter, MEDP stock was acquired by institutional investors including:
  1. Invesco Ltd.
  2. Proficio Capital Partners LLC
  3. Raymond James Financial Inc.
  4. Norges Bank
  5. GW&K Investment Management LLC
  6. Fundsmith LLP
  7. Spyglass Capital Management LLC
  8. AQR Capital Management LLC